The genes targeted by both NR2F1 and the 11 miRNAs that we identified bioinformatically have previously been implicated in hearing loss (Nr2f1, Crym, Snai2, Gjb2) [11,90–94] and cancer (Pdgfrα, Eln, Jun) [52,95–98], as well as inner ear developmental regulators (Nr2f1, Notch1, Jag 1, Nptx1, Runx1) [7,8,22,99], as listed in Tables S4 & S5 in File S1. The gene discussed is NR2F1; the disease is cancer.